Novel high efficient coatings for anti-microbial surgical sutures using chlorhexidine in fatty acid slow-release carrier systems

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Obermeier, Andreas ^a   Schneider, Jochen ^a   Wehner, Steffen ^a   Matl, Florian Dominik ^a   Schieker, Matthias ^b   Von Eisenhart Rothe, Rüdiger ^a   Stemberger, Axel ^a   Burgkart, Rainer ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE ACETATE; FATTY ACID; LAURIC ACID; PALMITIC ACID; TRICLOSAN; BIOMATERIAL; CHLORHEXIDINE; DELAYED RELEASE FORMULATION; ENZYME INHIBITOR; TOPICAL ANTIINFECTIVE AGENT;

ABSORBABLE SUTURE; AGAR DIFFUSION; ANIMAL CELL; ANTIBACTERIAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; ASSAY; BIOCOMPATIBILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY ASSAY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ELUTION; MATERIAL COATING; MOUSE; NONHUMAN; POLYGLACTIN SUTURE; SLOW RELEASE FORMULATION; STANDARDIZATION; STAPHYLOCOCCUS AUREUS; SUTURE; TENSILE STRENGTH; CHEMISTRY; DELAYED RELEASE FORMULATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; PHARMACOKINETICS; PHARMACOLOGY;

ANTI-INFECTIVE AGENTS, LOCAL; CHLORHEXIDINE; COATED MATERIALS, BIOCOMPATIBLE; DELAYED-ACTION PREPARATIONS; ENZYME INHIBITORS; HUMANS; PALMITIC ACID; STAPHYLOCOCCUS AUREUS; SUTURES;

EID: 84903647769     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101426     Document Type: Article

References (38)

1. Young B, Ng TM, Teng C, Ang B, Tai HY, et al. (2011) Nonconcordance with surgical site infection prevention guidelines and rates of surgical site infections for general surgical, neurological, and orthopedic procedures. Antimicrobial agents and chemotherapy 55: 4659-4663.
2. Hranjec T, Swenson BR, Sawyer RG (2010) Surgical site infection prevention: how we do it. Surgical Infections 11: 289-294.
3. Leaper DJ (2010) Surgical-site infection. The British journal of surgery 97: 1601-1602.
4. Baracs J, Huszar O, Sajjadi SG, Horvath OP (2011) Surgical site infections after abdominal closure in colorectal surgery using triclosan-coated absorbable suture (PDS Plus) vs. uncoated sutures (PDS II): a randomized multicenter study. Surgical Infections 12: 483-489.
5. Barnett TE (2007) The Not-So-Hidden Costs of Surgical Site Infections. AORN journal 86: 249-258.
6. Eiff C, Jansen B, Kohnen W, Becker K (2005) Infections Associated with Medical Devices. Drugs 65: 179-214.
7. Geiger D, Debus ES, Ziegler UE, Larena-Avellaneda A, Frosch M, et al. (2005) Capillary activity of surgical sutures and suture-dependent bacterial transport: a qualitative study. Surg Infect (Larchmt) 6: 377-383.
8. Kathju S, Nistico L, Hall-Stoodley L, Post JC, Ehrlich GD, et al. (2009) Chronic surgical site infection due to suture-associated polymicrobial biofilm. Surg Infect (Larchmt) 10: 457-461.
9. Katz S, Izhar M, Mirelman D (1981) Bacterial adherence to surgical sutures. A possible factor in suture induced infection. Ann Surg 194: 35-41.
10. Mingmalairak C (2011) Antimicrobial Sutures: New Strategy in Surgical Site Infections. In: Mendez-Vilas A, editor. Science against Microbial Pathogens: Communicating Current Research and Technological Advances: Formatex Research Center. pp. 313-323.
11. Edmiston CE, Seabrook GR, Goheen MP, Krepel CJ, Johnson CP, et al. (2006) Bacterial adherence to surgical sutures: can antibacterial-coated sutures reduce the risk of microbial contamination? J Am Coll Surg 203: 481-489.
12. Ming X, Rothenburger S, Nichols MM (2008) In vivo and in vitro antibacterial efficacy of PDS plus (polidioxanone with triclosan) suture. Surgical Infections 9: 451-457.
13. Justinger C, Schuld J, Sperling J, Kollmar O, Richter S, et al. (2011) Triclosancoated sutures reduce wound infections after hepatobiliary surgery - a prospective non-randomized clinical pathway driven study. Langenbeck's Archives of Surgery: 1-6.
14. Justinger C, Slotta JE, Ningel S, Gräber S, Kollmar O, et al. (2013) Surgical-site infection after abdominal wall closure with triclosan-impregnated polydioxanone sutures: Results of a randomized clinical pathway facilitated trial (NCT00998907). Surgery 154: 589-595.
15. Stone J, Gruber TJ, Rozzelle CJ (2010) Healthcare savings associated with reduced infection rates using antimicrobial suture wound closure for cerebrospinal fluid shunt procedures. Pediatr Neurosurg 46: 19-24.
16. Wang ZX, Jiang CP, Cao Y, Ding YT (2013) Systematic review and metaanalysis of triclosan-coated sutures for the prevention of surgical-site infection. British Journal of Surgery 100: 465-473.
17. Fujita T (2010) Antibiotic-coated surgical sutures against surgical site infection. Surgery 147: 464-465; author reply 465-466.
18. Chang WK, Srinivasa S, Morton R, Hill AG (2012) Triclosan-impregnated sutures to decrease surgical site infections: systematic review and meta-analysis of randomized trials. Ann Surg 255: 854-859.
19. Williams N, Sweetland H, Goyal S, Ivins N, Leaper DJ (2011) Randomized trial of antimicrobial-coated sutures to prevent surgical site infection after breast cancer surgery. Surgical Infections 12: 469-474.
20. Mingmalairak C, Ungbhakorn P, Paocharoen V (2009) Efficacy of antimicrobial coating suture coated polyglactin 910 with tricosan (Vicryl plus) compared with polyglactin 910 (Vicryl) in reduced surgical site infection of appendicitis, double blind randomized control trial, preliminary safety report. J Med Assoc Thai 92: 770-775.
21. Cooney CM (2010) Triclosan comes under scrutiny. Environ Health Perspect 118: A242.
22. Yazdankhah SP, Scheie AA, Hoiby EA, Lunestad BT, Heir E, et al. (2006) Triclosan and antimicrobial resistance in bacteria: an overview. Microbial drug resistance 12: 83-90.
23. Aiello AE, Larson EL, Levy SB (2007) Consumer antibacterial soaps: effective or just risky? Clin Infect Dis 45 Suppl 2: S137-147.
24. Segers P, Speekenbrink RG, Ubbink DT, van Ogtrop ML, de Mol BA (2006) Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. JAMA 296: 2460-2466.
25. Rupp ME, Lisco SJ, Lipsett PA, Perl TM, Keating K, et al. (2005) Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 143: 570-580.
26. Sanders D, Lambie J, Bond P, Moate R, Steer JA (2013) An in vitro study assessing the effect of mesh morphology and suture fixation on bacterial adherence. Hernia 17: 779-789.
27. Timsit JF, Mimoz O, Mourvillier B, Souweine B, Garrouste-Orgeas M, et al. (2012) Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med 186: 1272-1278.
28. Menderes G, Athar Ali N, Aagaard K, Sangi-Haghpeykar H (2012) Chlorhexidine-alcohol compared with povidone-iodine for surgical-site antisepsis in cesarean deliveries. Obstet Gynecol 120: 1037-1044.
29. Suwanpimolkul G, Pongkumpai M, Suankratay C (2008) A randomized trial of 2% chlorhexidine tincture compared with 10% aqueous povidone-iodine for venipuncture site disinfection: Effects on blood culture contamination rates. J Infect 56: 354-359.
30. Hubner NO, Matthes R, Koban I, Randler C, Muller G, et al. (2010) Efficacy of chlorhexidine, polihexanide and tissue-tolerable plasma against Pseudomonas aeruginosa biofilms grown on polystyrene and silicone materials. Skin Pharmacology and Physiology 23 Suppl: 28-34.
31. Matl FD, Zlotnyk J, Obermeier A, Friess W, Vogt S, et al. (2009) New Anti-infective Coatings of Surgical Sutures Based on a Combination of Antiseptics and Fatty Acids. Journal of Biomaterials Science, Polymer Edition 20: 1439-1449.
32. Schierholz JM, Beuth J (2001) Implant infections: a haven for opportunistic bacteria. Journal of Hospital Infection 49: 87-93.
33. Weinstein RA, Darouiche RO (2001) Device-Associated Infections: A Macroproblem that Starts with Microadherence. Clinical Infectious Diseases 33: 1567- 1572.
34. CLSI (2012) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard - Ninth Edition. CLSI document M07-A9 Clinical and Laboratory Standards Institute.
35. Ethicon (2010) Ihr zusätzlicher Schutz vor postoperativen Wundinfektionen, PLUS Nahtmaterial - ein neues Mab an Sicherheit Brochures Plus sutures (B-nr 178). Norderstedt, Germany: Ethicon GmbH a Company of Johnson & Johnson.
36. Leaper D, Assadian O, Hubner N-O, McBain A, Barbolt T, et al. (2011) Antimicrobial sutures and prevention of surgical site infection: assessment of the safety of the antiseptic triclosan. International Wound Journal 8: 556-566.
37. Matl FD, Obermeier A, Repmann S, Friess W, Stemberger A, et al. (2008) New anti-infective coatings of medical implants. Antimicrob Agents Chemother 52: 1957-1963.
38. Obermeier A, Matl FD, Schwabe J, Zimmermann A, Kühn KD, et al. (2012) Novel fatty acid gentamicin salts as slow-release drug carrier systems for anti-infective protection of vascular biomaterials. J Mater Sci Mater Med 23: 1675-1683.